By non-invasively predicting FOXM1 mRNA expression in HCC tissues using dual-region CT radiomics technology, clinicians can gain invaluable insights into the tumor’s molecular landscape even before surgical intervention. This evidence concerns the gene FOXM1 and neoplasm.